Jun.01 — Kirill Dmitriev, chief executive officer at Russian Direct Investment Fund, discusses the coronavirus drug developed with the sovereign wealth fund’s backing, U.S.-Russia relations, and outlook for the ruble. He speaks with Bloomberg’s Taylor Riggs on “Bloomberg Markets.”